Reuters Events Pharma

Stop scaling tools. Start scaling outcomes. In pharma, the next leap in HCP engagement won't come from adding another AI platform to the stack. It will come from redesigning how humans, AI, data, and workflows operate together. Join Reuters Events on August 21, 2026 at 10:30am EDT for a timely discussion on how leading pharma teams are building hybrid human-AI operating models that turn engagement capability into measurable impact. This webinar brings together leaders across commercial operations, insights & analytics, medical content, marketing operations, and digital innovation to explore what optimized HCP engagement looks like in 2026. You'll hear from speakers at Shionogi Inc. (U.S.), MSD, Bayer, Gilead Sciences, and Azurity Pharmaceuticals on how to: - Embed AI into real workflows across commercial, marketing, and medical affairs - Address data silos by rethinking org design - Build a model where speed, scale, and compliance can work together Register for the webinar: https://lnkd.in/es5BaZMr #RECustomerUSA  #PharmaMarketing #HCPEngagement #AIinPharma

Every country is different when it comes to market access. Dirk Hoheisel, SVP and Head of Commercial International at CSL, breaks down the strategies helping to accelerate time to treatment, from navigating national and regional payers to bringing the right stakeholders to the table. 🎥 Watch the clip to hear his take on fast-tracking reimbursement, and watch the full interview here: https://lnkd.in/eTKvtgtk #MarketAccess #Pharma #ATMP

Clinical trial sites are stretched. Patients face real barriers to participation. Protocols are accumulating complexity with every cycle. And AI is moving into parts of the trial process that used to depend almost entirely on human labour. The next 18 to 24 months will test whether sponsors can build trials that are easier to run - without weakening the evidence. Leading clinical development teams from Astellas, Regeneron, Genentech, Roche, Bayer, Eisai, and Takeda have shared their thinking across five critical areas. We've brought it together in one whitepaper. Download your free copy today: https://lnkd.in/ekJAx3yP #REclinicalUSA #ClinicalTrials #ClinicalDevelopment #Pharma #DrugDevelopment

Is your AI, data and digital investment actually paying off? Or just adding another layer of complexity? 👉 Tell us in our 2026 pharma survey: https://lnkd.in/efz-6sqz We're asking leaders across commercial, medical, patient engagement, market access and digital to share their real experience. It’s anonymous and takes under 5 minutes. By answering, you will get: 🔹 Early access to the full report 🔹 $200 off your next Reuters Events Pharma ticket 🔹 A say in shaping the industry benchmark #pharmasurvey #pharmaindustry #pharma

⏰ Super Early Bird ends this Friday, July 31st – save £900. Don't miss out. The pharma commercial leaders are already confirmed. Are you on the list? Reuters Events: Pharma Commercial Data & Tech 2026 is bringing together 250+ senior leaders from AstraZeneca, Pfizer, Roche, GSK, Bayer, Takeda, and more - all in one room, London, 4–5 November. The agenda is clear: stop piloting. Start scaling. Fragmented data, disconnected CRM, siloed teams, and AI that never leaves the proof-of-concept stage - these are the barriers holding commercial pharma back. This is where the industry comes to break through them. Discover more and secure your Super Early Bird spot before 31 July: https://lnkd.in/eZgHfYkv #REPharmaTech #PharmaCommercial #DigitalHealth #PharmaAI

Inside July's Pharma Insights Email Newsletter: 🎙️ Amgen's CMO on why direct-to-patient access is ready for prime time 🧪 How to recruit faster & represent better in clinical trials 🔍 Why AI deployments might be hardening pharma's silos, not dissolving them That's just a taste. Get the full edition, sign up for August here: https://bit.ly/3sivHM7 #pharmanews #pharmainsights #pharmaindustry

I am thrilled to share that I will be speaking at Reuters Pharma Clinical Innovation 2026 this October together with 200+ esteemed industry colleagues. Learn more and join me here: https://bit.ly/4psBHuQ I look forward to contributing to the conversations driving meaningful change in clinical research and sharing the site perspective with leaders across the industry. Don't miss out! Reuters Events Pharma #REclinicalUSA

Trust is the real currency in pharma right now. From AI oversight to patient access to conversational marketing, read this issue to unpack where it's breaking down, and where it's being rebuilt. Plus, tell us what's really changing in the industry in our survey (and grab $200 off your next Reuters Events Pharma ticket). 📩 Read Issue 67 here...

What is the future of patient access to innovative therapies? "It will never be the one-size-fits-all situation,” says Dirk Hoheisel, SVP and Head of Commercial International at CSL, about the shift he believes is coming in how treatments get funded. Watch the clip to find out more, and catch the full interview here: https://lnkd.in/eTKvtgtk #MarketAccess #PatientAccess #PharmaInnovation

Pharma is in the middle of one of its most transformative periods in years. Restructures. AI and digital investment. Shifting market access pressures. Economic uncertainty. But how much of this is creating real impact, and how much is just adding complexity? We want to hear from industry leaders across the commercial ecosystem. ✅ Anonymous ✅ ~5 minutes ✅ Early access to the full report ✅ $200 off your next Reuters Event 👉 Take the Reuters Events Pharma Survey 2026: https://lnkd.in/efz-6sqz #pharmasurvey #pharmaindustry #pharma